Last edition
News about "Hetero"
Dr. Reddy's, Hetero to Produce Affordable Generic Lenacapavir For HIV Prevention by 2027
Indian pharmaceutical companies Dr. Reddy’s Laboratories and Hetero Labs (Hetero) have signed landmark agreements to manufacture generic versions of lenacapavir, a revolutionary long-acting HIV prevention drug, which will be available at roughly USD 40 per patient per year in low- and middle-income countries (LMICs) starting in 2027.
Hetero | 29/09/2025 | By Dineshwori | 208
Hetero acquires manufacturing plant at Penjerla in Telangana
Hetero aims to boost its sterile pharmaceutical manufacturing capabilities, along with biosimilars and biologics production, while generating 2000 new jobs
Hetero | 17/10/2022 | By Sudeep Soparkar | 892
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy